RDY Shareholders Equity Per Share from 2010 to 2025

RDY Stock  USD 15.53  0.78  5.29%   
Dr Reddys Shareholders Equity Per Share yearly trend continues to be fairly stable with very little volatility. Shareholders Equity Per Share is likely to outpace its year average in 2025. During the period from 2010 to 2025, Dr Reddys Shareholders Equity Per Share regression line of annual values had r-squared of  0.07 and arithmetic mean of  1,207. View All Fundamentals
 
Shareholders Equity Per Share  
First Reported
2010-12-31
Previous Quarter
K
Current Value
2.1 K
Quarterly Volatility
K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Dr Reddys financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Dr Reddys' main balance sheet or income statement drivers, such as Interest Expense of 2.1 B, Total Revenue of 337.1 B or Gross Profit of 197.6 B, as well as many indicators such as Price To Sales Ratio of 0.7, Dividend Yield of 0.0272 or PTB Ratio of 0.85. RDY financial statements analysis is a perfect complement when working with Dr Reddys Valuation or Volatility modules.
  
Build AI portfolio with RDY Stock
Check out the analysis of Dr Reddys Correlation against competitors.

Latest Dr Reddys' Shareholders Equity Per Share Growth Pattern

Below is the plot of the Shareholders Equity Per Share of Dr Reddys Laboratories over the last few years. It is Dr Reddys' Shareholders Equity Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Dr Reddys' overall financial position and show how it may be relating to other accounts over time.
Shareholders Equity Per Share10 Years Trend
Pretty Stable
   Shareholders Equity Per Share   
       Timeline  

RDY Shareholders Equity Per Share Regression Statistics

Arithmetic Mean1,207
Geometric Mean857.56
Coefficient Of Variation82.92
Mean Deviation682.81
Median935.02
Standard Deviation1,001
Sample Variance1M
Range4.3K
R-Value0.26
Mean Square Error1M
R-Squared0.07
Significance0.33
Slope54.64
Total Sum of Squares15M

RDY Shareholders Equity Per Share History

2025 2101.87
2024 2001.78
2023 1684.85
2022 1402.48
2021 1148.56
2020 1055.09
2019 935.02

About Dr Reddys Financial Statements

Dr Reddys investors use historical fundamental indicators, such as Dr Reddys' Shareholders Equity Per Share, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Dr Reddys. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Shareholders Equity Per ShareK2.1 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for RDY Stock Analysis

When running Dr Reddys' price analysis, check to measure Dr Reddys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Reddys is operating at the current time. Most of Dr Reddys' value examination focuses on studying past and present price action to predict the probability of Dr Reddys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Reddys' price. Additionally, you may evaluate how the addition of Dr Reddys to your portfolios can decrease your overall portfolio volatility.